| Serial Number | 79311144 |
| Word Mark | TIGEN |
| Filing Date | Thursday, February 4, 2021 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Thursday, January 30, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, February 15, 2022 |
| Goods and Services | Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases |
| Goods and Services | Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals |
| Goods and Services | Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists |
| Goods and Services | Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions |
| Goods and Services | Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, development of food supplement; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tigen Pharma SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Party Name | Tigen Pharma SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Friday, May 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 20, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, May 25, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 20, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 27, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, September 14, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, September 13, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 14, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, September 14, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, January 7, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, October 4, 2021 | REFUSAL PROCESSED BY IB |
| Friday, January 7, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, January 7, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, January 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, January 10, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, January 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, January 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 10, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, January 10, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, January 10, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, January 11, 2022 | ASSIGNED TO LIE |
| Monday, January 10, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 11, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, February 14, 2022 | NOTIFICATION PROCESSED BY IB |
| Wednesday, January 26, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 26, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 26, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, February 15, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 15, 2022 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Monday, March 28, 2022 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, March 16, 2022 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| Wednesday, March 16, 2022 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| Sunday, December 31, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, April 10, 2022 | REFUSAL PROCESSED BY IB |
| Sunday, June 5, 2022 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Tuesday, August 2, 2022 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Wednesday, November 8, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, November 8, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, December 11, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, January 29, 2025 | OPPOSITION DISMISSED NO. 999999 |
| Wednesday, January 29, 2025 | OPPOSITION TERMINATED NO. 999999 |
| Wednesday, January 29, 2025 | TTAB RELEASE CASE TO TRADEMARKS |